Ligand validation:8K1G

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 8K1G designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8K1G_EDO_A_403	51%	75%	0.13	0.884	0.49	0.5	-	-	0	0	100%	1
8K1G_EDO_A_404	50%	73%	0.119	0.868	0.54	0.51	-	-	0	0	100%	1
8K1G_EDO_A_407	37%	85%	0.231	0.928	0.3	0.43	-	-	5	0	100%	0.74
8K1G_EDO_A_402	36%	67%	0.142	0.834	0.51	0.76	-	-	1	0	100%	1
8K1G_EDO_A_406	33%	76%	0.152	0.831	0.49	0.47	-	-	1	0	100%	1
8K1H_EDO_A_403	52%	72%	0.147	0.905	0.48	0.61	-	-	1	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.